CSBR:NASDAQ
Champions Oncology Inc
$4.36
arrow_downward
-0.96%(-0.042) 1D
Nov 20, 1:29:57 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.45
High
$4.45
Low
$4.35
Mkt. cap
60.66M
Avg. vol.
6.97K
Volume
7.58K
52-wk high
$8.31
52-wk low
$4.35
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.45
High
$4.45
Low
$4.35
Mkt. cap
60.66M
Avg. vol.
6.97K
Volume
7.58K
52-wk high
$8.31
52-wk low
$4.35
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Session Movers: Fair Isaac Leads Gainers, Coherent Leads Decliners
WHEC.com
·
1 hour ago
US stocks tumble, and the S&P 500 drops as the sell-off for AI stocks accelerates
Traders Union
·
2 hours ago
S&P 500 P/E multiples range from 15.7x to 19.6x depending on EPS assumptions, Michael Kantro notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com